Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
Blood (2008) 112 (12): 4445–4451.
Currently there are no citedby results. Try again later.
